This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
AET
This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.
It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.
α-Ethyltryptamine (also known as a-ET, Monase) is a short-acting synthetic psychedelic that was first sold as a pharmaceutical antidepressant (Monase) in 1961. It was emergency scheduled (made illegal) on March 12, 1993 and has remained uncommon since. [1]
α-Ethyltryptamine is structurally and pharmacologically related to aMT, α-methyltryptamine.
Subjective effects
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWikicontributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
As such, it may contain incomplete or wrong information. You can help by expanding it.
AET is Schedule 1 in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license. AET was emergency scheduled on March 12, 1993 and the permanently added to Schedule I on September 12, 1994
↑Huang XM, Johnson MP, Nichols DE (July 1991). "Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase)". European Journal of Pharmacology. 200 (1): 187–190. doi:10.1016/0014-2999(91)90686-k. PMID1722753.